Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis
The IMID Forum
- Published
- November 13, 2025
- Duration
- 14:37
- Summary source
- description
- Last updated
- Jun 21, 2026
Discusses Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the wo…
Summary
Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered the Association between adalimumab dosing interval and uveitis recurrence in patients with ankylosing spondylitis.
Intelligent report
Sign in to read teasers, or upgrade to Research Pro to commission a new dossier for this episode. Learn more →
Show notes
Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered the Association between adalimumab dosing interval and uveitis recurrence in patients with ankylosing spondylitis.